Search Results - "Covela Rúa, M."
-
1
Efficacy and safety of trifluridine/tipiracil in third-line and beyond for the treatment of patients with metastatic colorectal cancer in routine clinical practice: patterns of use and prognostic nomogram
Published in Clinical & translational oncology (01-03-2020)“…Introduction Trifluridine/tipiracil combination has shown a benefit over placebo in the treatment of patients with chemorefractory metastatic colorectal cancer…”
Get full text
Journal Article -
2
FOLFIRI plus panitumumab as second-line treatment in mutated RAS metastatic colorectal cancer patients who converted to wild type RAS after receiving first-line FOLFOX/CAPOX plus bevacizumab-based treatment: Phase II CONVERTIX trial
Published in Annals of oncology (01-07-2019)Get full text
Journal Article -
3
Is there any affordable and reliable score in local gastric cancer?
Published in Annals of oncology (01-07-2019)Get full text
Journal Article -
4
-
5
-
6
P-122 Vitamin D-based score in gastric cancer
Published in Annals of oncology (01-06-2022)Get full text
Journal Article -
7
P-089FOLFIRI plus panitumumab as second-line treatment in mutated RAS metastatic colorectal cancer patients who converted to wild type RAS after receiving first-line FOLFOX/CAPOX plus bevacizumab-based treatment: Phase II CONVERTIX trial
Published in Annals of oncology (01-07-2019)Get full text
Journal Article -
8
-
9
-
10
P-123 Outcomes and predictive factors of regorafenib benefit in patients with metastatic colorectal cancer in a real-life setting
Published in Annals of oncology (01-07-2020)Get full text
Journal Article -
11
-
12
-
13
P-219Is there any affordable and reliable score in local gastric cancer?
Published in Annals of oncology (01-07-2019)Get full text
Journal Article -
14
588PEfficacy and safety of FOLFIRI/Aflibercept (FA) in elderly population with mCRC after failure of oxaliplatin-based chemotherapy
Published in Annals of oncology (01-10-2019)“…Abstract Background Aflibercept (Af) significantly improves progression-free (PFS) and overall survival (OS) when added to FOLFIRI, in the overall population…”
Get full text
Journal Article -
15
Efficacy and safety of FOLFIRI/Aflibercept (FA) in elderly population with mCRC after failure of oxaliplatin-based chemotherapy
Published in Annals of oncology (01-10-2019)Get full text
Journal Article -
16
588P - Efficacy and safety of FOLFIRI/Aflibercept (FA) in elderly population with mCRC after failure of oxaliplatin-based chemotherapy
Published in Annals of oncology (01-10-2019)“…Aflibercept (Af) significantly improves progression-free (PFS) and overall survival (OS) when added to FOLFIRI, in the overall population of patients (pts)…”
Get full text
Journal Article -
17
Interstitial lung disease associated with oxaliplatin: description of two cases
Published in Clinical & translational oncology (01-05-2009)Get full text
Journal Article